Inhibitor treatment: State of the art

被引:25
作者
Shapiro, A [1 ]
机构
[1] Indiana Hemophilia & Thrombosis Ctr Inc, Indianapolis, IN 46260 USA
关键词
D O I
10.1016/S0037-1963(01)90144-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:26 / 34
页数:9
相关论文
共 37 条
[1]   The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complications [J].
Baudo, F ;
Redaelli, R ;
Caimi, TM ;
Mostarda, G ;
Somaini, G ;
de Cataldo, F .
THROMBOSIS RESEARCH, 2000, 99 (01) :21-24
[2]  
Bech RM, 1996, HAEMOSTASIS, V26, P135
[3]  
Chuansumrit A, 2000, HAEMOPHILIA, V6, P61
[4]  
COOPER HA, 2000, HAEMOPHILIA, V6, P297
[5]  
d'Oiron R, 2000, THROMB HAEMOSTASIS, V83, P644
[6]  
GRINGERI A, 1991, HAEMOSTASIS, V21, P1
[7]  
Grossmann RE, 2000, THROMB HAEMOSTASIS, V83, P633
[8]  
Hedner U, 1998, HAEMOPHILIA, V4, P355
[9]  
Hedner Ulla, 1993, Transfusion Medicine Reviews, V7, P78, DOI 10.1016/S0887-7963(93)70126-1
[10]  
Jiménez-Yuste V, 2000, HAEMOPHILIA, V6, P588